Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin
- PMID: 914634
- DOI: 10.3109/03630267709003417
Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin
Abstract
We have examined the effect of 2, 3-diphosphoglycerate (DPG) on the solubility of deoxy-sickle hemoglobin (deoxy-Hb S) under conditions such that concentration, pH, and osmolarity of deoxy-Hb S solutions approached physiological. The range of DPG/Hb molar ratios encompassed the extremes found for this ratio in erythrocytes from individuals with sickle cell anemia. After monomer-polyer equilibrium had been established, the phases were separated by centrifugation and assayed for concentrations of Hb and DPG. DPG had no effect on the solubility of deoxy-Hb S. Furthermore, at DPG/Hb molar ratios less than one, there was no preferential incorporation of deoxy-Hb S containing bound DPG into polymers. At DPG/Hb molar ratios greater than one, concentrations of free DPG in monomer and polymer phases were virtually identical. Thus, under the specified equilibrium conditions, DPG is not a determining factor in the polymerization of deoxy-Hb S.
Similar articles
-
2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.Blood. 1990 Sep 1;76(5):1028-36. Blood. 1990. PMID: 2393711
-
The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S.Arch Biochem Biophys. 1986 Sep;249(2):301-5. doi: 10.1016/0003-9861(86)90006-8. Arch Biochem Biophys. 1986. PMID: 3753004
-
Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.J Biol Chem. 1985 Nov 15;260(26):13897-900. J Biol Chem. 1985. PMID: 4055763
-
Pathophysiology of sickle cell anemia.Hematol Oncol Clin North Am. 1996 Dec;10(6):1241-53. doi: 10.1016/s0889-8588(05)70397-x. Hematol Oncol Clin North Am. 1996. PMID: 8956013 Review.
-
The polymerization of sickle hemoglobin in solutions and cells.Experientia. 1993 Feb 15;49(2):110-7. doi: 10.1007/BF01989414. Experientia. 1993. PMID: 8440349 Review.
Cited by
-
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.Hematol Oncol Clin North Am. 2014 Apr;28(2):217-31. doi: 10.1016/j.hoc.2013.11.001. Epub 2014 Jan 21. Hematol Oncol Clin North Am. 2014. PMID: 24589263 Free PMC article. Review.
-
New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?Br J Haematol. 2016 Oct;175(1):24-30. doi: 10.1111/bjh.14264. Epub 2016 Sep 8. Br J Haematol. 2016. PMID: 27605087 Free PMC article. Review.
-
Sickling crises at high altitudes.West J Med. 1982 Aug;137(2):138-9. West J Med. 1982. PMID: 18749180 Free PMC article. No abstract available.
-
FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice.Blood Adv. 2021 May 11;5(9):2385-2390. doi: 10.1182/bloodadvances.2020003604. Blood Adv. 2021. PMID: 33944896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources